You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 117 No. 11, November 1991 TABLE OF CONTENTS
  Archives
  •  Online Features
  PAPERS READ BEFORE THE AMERICAN SOCIETY FOR HEAD AND NECK SURGERY
 This Article
 •References
 •Full text PDF
 • Reply to article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

The Effect of Hyperbaric Oxygen on Growth of Human Squamous Cell Carcinoma Xenografts

Don B. Headley, MD; Markus Gapany, MD; Douglas E. Dawson, MD; Grant D. Kruse, MD; Robert A. Robinson, MD; Brian F. McCabe, MD

Arch Otolaryngol Head Neck Surg. 1991;117(11):1269-1272.


Abstract

• Hyperbaric oxygen is an important adjunct to the treatment of patients with head and neck cancer with existing or recurrent wound healing problems. Anecdotal clinical observations and a recent study of chemically induced oral cancer in hamsters have raised concern that hyperbaric oxygen therapy may accelerate tumor growth in such patients. This study evaluated the effect of hyperbaric oxygen therapy on the growth of human squamous cell carcinoma xenografts in a proved animal model. Fresh tumor specimens from three patients with head and neck squamous cell carcinoma of varying degrees of differentiation were first subcutaneously transplanted into a nude mouse host. Growing xenografts were then transplanted into one of three mouse groups. Half of the mice in each group were given hyperbaric oxygen therapy. The transplant volume as an index of tumor growth was measured in controls and mice given hyperbaric oxygen therapy six times during the 3-week course. Xenograft growth was almost linear in all mice. No statistical difference in overall group mean growth rates was observed in mice given hyperbaric oxygen or control mice regardless of the degree of tumor differentiation. Xenograft tissue from all mice was microscopically examined for tumor mitotic indices and degree of differentiation. This study suggests that hyperbaric oxygen therapy has no effect on established tumor xenograft growth.

(Arch Otolaryngol Head Neck Surg. 1991;117:1269-1272)



Author Affiliations

From the Departments of Otolaryngology—Head and Neck Surgery (Drs Headley, Gapany, and McCabe), Anesthesia (Dr Kruse), and Pathology (Dr Robinson), University of Iowa, Iowa City. Dr Dawson is in private practice in Iowa City.


Footnotes

Accepted for publication July 17, 1991.

Read before the American Society for Head and Neck Surgery, Waikaloa, Hawaii, May 8, 1991.

Reprint requests to Department of Otolaryngology—Head and Neck Surgery, University of Iowa, Iowa City, IA 52242 (Dr Headley).



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1991 American Medical Association. All Rights Reserved.